IQV - IQVIA HOLDINGS INC.

163.85
-5.550   -3.387%

Share volume: 1,526,942
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$169.40
-5.55
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
48%
Profitability 31%
Dept financing 50%
Liquidity 13%
Performance 72%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.86%
1 Month
-5.98%
3 Months
-27.85%
6 Months
-9.33%
1 Year
-7.63%
2 Year
-35.21%
Key data
Stock price
$163.85
P/E Ratio 
28.23
DAY RANGE
$162.36 - $168.54
EPS 
$7.91
52 WEEK RANGE
$134.64 - $247.04
52 WEEK CHANGE
-$7.06
MARKET CAP 
38.387 B
YIELD 
N/A
SHARES OUTSTANDING 
169.700 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,640,396
AVERAGE 30 VOLUME 
$1,920,768
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news